1. Retreatment of
non-sustained virological responders to DAAs
DR.MFAROUK.GIT@HOTMAIL.COM
By
Mohamed Farouk
M.sc., Tropical medicine and Gastroenterology
Assiut Center for Control of Viral Hepatitis
M.Farouk ... 2015
4. M.Farouk ... 2015
Should we do genotyping before retreatment?
Should we do genotyping before initial therapy?
Is giving ribavirin to patients with intolerance to it, anaemia.
Cirrhosis is suitable? and if not what should we do?
Should I choose a pangeotypic rigemen instead, like
daclatasvir?